Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOCOVRI on Gait in Parkinson's Disease
NCT04387773Phase 4Completed
- Sponsor
- Oregon Health & Science University
- Start
- Nov 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amantadine in Parkinson's disease (PD), levodopa-induced dyskinesia (LID), sponsored by Oregon Health & Science University. Started Nov 2020; status: completed.
02
Drugs
amantadine
03
Conditions
Parkinson's disease (PD)levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on NCT04387773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04387773.